← Hub
The frame
The supplement layer is your call — that is the basis of this whole document. The team is for exactly two
things: clinical facts only they hold (labs, healing, imaging, bleeding risk) and
prescribed-medication changes (telmisartan, the stimulant). Everything below is a fact to
obtain so you can finish the call — never an approval to seek.
Today · records, not clinicians
- Call VM medical records. Request the 6/29–7/3 enteroscopy pathology report.
Ask specifically: "Was gastric histology sent, or only a rapid urease test (CLOtest)?" A negative CLOtest from that admission is worth ~75% NPV. Negative histology is worth considerably more.
- From the same admission, request the PT / INR values.
Nobody has looked. EPI causes vitamin K malabsorption. If PT was prolonged, the bleed had a coagulopathic contributor.
Dr. Kuhlman · primary care, cardiovascular
1 · The hyponatremia panel — add to this week's draw
My hyponatremia has never been worked up. I've been supplementing about 68 milliequivalents of sodium a day
for years and moved 2 mEq/L. I'd like serum osmolality, urine osmolality, urine sodium, urine urea, serum uric
acid, an 8 AM cortisol, and TSH. I want to know the mechanism before we touch the ARB.
2 · Iron — ask for the right test and the right drug · ✅ settled 9/23 — INFeD 1,000 mg given
Given the recent bleed and my EPI, I'd like Ret-He or reticulocyte hemoglobin rather than ferritin alone —
ferritin is an acute-phase reactant and I'm four weeks post-op. If IV iron is indicated, I'd specifically like
ferric derisomaltose (Monoferric), not ferric carboxymaltose, because of the hypophosphatemia difference.
3 · Add copper and ceruloplasmin to the 8/1 draw
I'd like serum copper and ceruloplasmin on the August draw. I'm running zinc at a 15-to-1 ratio with copper,
and I want to confirm copper status directly. Please read them against the CRP on the same panel — both are
acute-phase reactants and I'm still post-op.
4 · The BP re-baseline — bring him the numbers
My blood pressure has re-baselined substantially. Across 59 readings, my fasted morning average at 40 mg
is now 120/66, down from about 137/67 in early July, and my pulse pressure dropped from about 70 to 54 —
which fits the anemia correcting rather than anything I changed. Given that, does 80 mg have any remaining
indication? And if the case is nephroprotection rather than blood pressure, I'd like the UACR result to
drive that decision.
5 · 🆕 The iron reaction — a plan without acetaminophen or NSAIDs · send to Kuhlman · 🆕 window ended ~9/29; still owed for any future total-dose infusion
I received INFeD (iron dextran) today, 9/23, at Providence. Two questions for the next few days, since the
label's delayed reaction (aches, back pain, chills, fever, nausea) usually starts 24-48 hours out, lasts 3-4 days,
and runs into the weekend. First: acetaminophen is a documented adverse reaction for me (Virginia Mason, July) and
NSAIDs are contraindicated (GI bleed and ulcer history). What would you like me to use if the delayed reaction
comes, and who should I contact over the weekend? Second: my WBC and CRP tend to read normal even when something
is wrong, and fever, chills and back pain are also my warning signs for cholangitis or a pancreatitis flare after
the Frey. At what point do you want me seen rather than waiting it out as an iron reaction? For any labs in the
coming weeks: the INFeD label notes it can falsely raise bilirubin and falsely lower calcium, and serum iron is
not reliable for about 3 weeks.
6 · 🆕 The 9/22 results — the ~10/21 recheck plus GGT · PTH · zinc · DXA · send to Kuhlman · ✅ sent — order confirmed 10/1
The full text lives in follow-ups C4, with a copy button — kept in one place so two copies cannot drift. 1,089 characters, plain ASCII. Open items 130, 133, 134. ✅ Done ⟨N 10-01⟩ — the recheck is ordered at Labcorp; its test list and date ⟨?⟩.
Dr. Wancata · surgery (HPB)
✅ ANSWERED 8/3 — ulcers confirmed healed. Every gate that named ulcer healing is released.
Still worth raising at the next contact: the eating window resumed 8/3 (noon → 8:30 PM), the 6:30 AM protein bite is cut, and Creon now paces across four eating occasions instead of five. Also for Murage and the PCP: both morning Adderall doses and the telmisartan are now taken fasted — a timing change in effect, not in dose.
🚫 MOOT 9/15 — Erinamax left the regimen ~9/8 · Erinamax — do this first, before the email
📦 Physical check · yours, not a clinician's
Read the bottle in your hand. Does the panel say "as ErinaPrime®" and
"Contains: Milk, Soy"? Write down the lot number.
ErinaPrime launched ~June 2026 and ND is mid-transition (older blue/white bottles, or the updated white ones).
A pre-June bottle is different material with a possibly different allergen declaration — and any
tolerance history on it does not transfer. This determines whether the rest is even the same question.
🚫 MOOT 9/15 — do not send · Nootropics Depot — one email · support@nootropicsdepot.com
I take Erinamax daily. I have exocrine pancreatic insufficiency and take prescription pancreatic enzymes, and
I avoid dairy for a non-allergic sensitivity, so I need more detail than the label carries. Four questions.
1. Quantitative batch data. The label says batch testing shows "non-detectable or trace levels"
of milk and soy — could you share the assay method, the LOD/LOQ, and results in ppm or mg per serving? A recent
CoA would be ideal. "Non-detectable" against a 2.5 ppm ELISA and against a 20 ppm one are very different figures for me.
2. Form of the soy in the medium. Is the soy component of the ErinaPrime fermentation medium a
hydrolysate or peptone, or intact soy flour / soy protein? Trypsin-inhibitor activity is the specific property I
need to characterise, and hydrolysed and heat-treated soy generally carry little to none.
3. Lot transition. When did Erinamax move to ErinaPrime raw material, and from which lot numbers
forward? I want to know whether the bottle I have is pre- or post-transition, since the allergen declaration
appears to be new. My lot number is ______.
4. Erinacine A specification. The panel declares 5 mg erinacine A per 1,000 mg — 0.5%, or 5 mg/g.
Nammex publishes ErinaPrime as standardized to 1% (10 mg/g). Is the 0.5% on your label a guaranteed minimum against
a higher-assaying material, or the actual assay for the grade you use? I dose by erinacine A rather than by capsule,
so a factor of two matters to me.
One note in case it's useful internally: several retailer listings and some of your own product copy still describe
Erinamax as "allergen-free," which now conflicts with the "Contains: Milk, Soy" statement on the label.
Yourself — one recall, no one to call
🏷 Where did "soy stops Creon working" come from?
A clinician (Puri? a dietitian?), your own experience, or a prior session's framing? It is
untagged in every rev, absent from the Creon FDA label, and unsupported by any PERT or EPI
literature — and it sat in the ❌ tier alongside acetaminophen and NSAIDs for the life of the document.
Authorship is not assumed in either direction. If a clinician said it, the rule regains a tier
it currently hasn't earned. If no one did, it stays ⚠️ and activity-gated.
Med reconciliation — everyone
Please update my chart: telmisartan is 40 mg, not 80 — I'm holding the step. Adderall is back to the full
prescribed 70 mg a day. Both VM and Providence still show the old figures.
Not a supplement question — a clinical one
Dark or tarry stool · visible blood · new dizziness · resting HR climbing · fever or rigors ·
any BP reading ≥180/120 → urgent care, not a message.